Amgen Revenue 2006-2018 | AMGN

Current and historical revenue for Amgen (AMGN) from 2006 to 2018. The sum of all revenue fields included for a company's operating activities. The current revenue for Amgen as of March 31, 2018 is .
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.002B $22.849B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Gilead Sciences (GILD) United States $100.380B 10.01
Biogen (BIIB) United States $74.904B 15.66
Celgene (CELG) United States $62.226B 12.37
Vertex Pharmaceuticals (VRTX) United States $46.529B 152.16
Illumina (ILMN) United States $44.907B 63.38
Regeneron Pharmaceuticals (REGN) United States $39.355B 23.36
Alexion Pharmaceuticals (ALXN) United States $30.349B 25.26
BioMarin Pharmaceutical (BMRN) United States $18.364B 0.00
Incyte (INCY) United States $14.887B 0.00
Seattle Genetics (SGEN) United States $10.750B 0.00
Alnylam Pharmaceuticals (ALNY) United States $10.280B 0.00
Bluebird Bio (BLUE) United States $9.092B 0.00
Sarepta Therapeutics (SRPT) United States $8.997B 0.00
BeiGene (BGNE) Cayman Islands $8.824B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.516B 68.69
QIAGEN (QGEN) Netherlands $8.424B 28.18
Exact Sciences (EXAS) United States $8.134B 0.00
Alkermes (ALKS) Ireland $6.995B 0.00
Exelixis (EXEL) United States $6.335B 25.71
Bio-Techne Corp (TECH) United States $5.729B 39.30
Integra LifeSciences Holdings (IART) United States $5.564B 29.86
Galapagos (GLPG) Belgium $5.260B 0.00
Ligand Pharmaceuticals (LGND) United States $4.724B 63.36
Immunomedics (IMMU) United States $4.251B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.242B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $4.117B 0.00
Array BioPharma (ARRY) United States $3.593B 0.00
China Biologic Products (CBPO) China $3.355B 22.16
Spark Therapeutics (ONCE) United States $3.265B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.006B 0.00
Myriad Genetics (MYGN) United States $2.993B 36.29
Medicines (MDCO) United States $2.972B 0.00
Amicus Therapeutics (FOLD) United States $2.940B 0.00
Blueprint Medicines (BPMC) United States $2.932B 0.00
Ascendis Pharma (ASND) Denmark $2.927B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.926B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.840B 0.00
Horizon Pharma Public (HZNP) Ireland $2.835B 17.35
Emergent Biosolutions (EBS) United States $2.712B 34.67
REGENXBIO (RGNX) United States $2.517B 58.37
Halozyme Therapeutics (HALO) United States $2.501B 38.60
Clovis Oncology (CLVS) United States $2.450B 0.00
Akcea Therapeutics (AKCA) United States $2.392B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.267B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.223B 0.00
Arena Pharmaceuticals (ARNA) United States $2.194B 0.00
Global Blood Therapeutics (GBT) United States $2.130B 0.00
Acceleron Pharma (XLRN) United States $2.119B 0.00
Repligen (RGEN) United States $2.096B 66.63
MyoKardia (MYOK) United States $2.005B 0.00
Puma Biotechnology (PBYI) United States $1.985B 0.00
Genomic Health (GHDX) United States $1.984B 350.44
Insmed (INSM) United States $1.964B 0.00
Cambrex (CBM) United States $1.844B 16.95
Atara Biotherapeutics (ATRA) United States $1.780B 0.00
Editas Medicine (EDIT) United States $1.724B 0.00
Aimmune Therapeutics (AIMT) United States $1.718B 0.00
AnaptysBio (ANAB) United States $1.713B 0.00
IMMURON LTD (IMRN) Australia $1.581B 0.00
Sangamo Therapeutics (SGMO) United States $1.538B 0.00
Solid Biosciences (SLDB) United States $1.525B 0.00
G1 THERAPEUTICS (GTHX) United States $1.496B 0.00
Mirati Therapeutics (MRTX) United States $1.495B 0.00
Innoviva (INVA) United States $1.490B 10.92
Audentes Therapeutics (BOLD) United States $1.429B 0.00
BIOHAVEN PHARM (BHVN) United States $1.426B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.422B 0.00
Acorda Therapeutics (ACOR) United States $1.393B 0.00
UniQure (QURE) Netherlands $1.356B 0.00
Intellia Therapeutics (NTLA) United States $1.351B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.346B 0.00
Myovant Sciences (MYOV) United Kingdom $1.323B 0.00
Denali Therapeutics (DNLI) United States $1.322B 0.00
Lion Biotechnologies (IOVA) United States $1.295B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.293B 0.00
Cellectis (CLLS) France $1.248B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.203B 0.00
Retrophin (RTRX) United States $1.200B 0.00
Athenex (ATNX) United States $1.178B 0.00
Reata Pharmaceuticals (RETA) United States $1.144B 0.00
NeoGenomics (NEO) United States $1.125B 232.67
Intra-Cellular Therapies (ITCI) United States $1.119B 0.00
WAVE Life Sciences (WVE) Singapore $1.100B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.074B 0.00
Revance Therapeutics (RVNC) United States $1.067B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.060B 0.00
DBV Technologies (DBVT) France $1.030B 0.00
Apellis Pharmaceuticals (APLS) United States $1.027B 0.00
Dynavax Technologies (DVAX) United States $0.968B 0.00
Epizyme (EPZM) United States $0.945B 0.00
CytomX Therapeutics (CTMX) United States $0.935B 0.00
Coherus BioSciences (CHRS) United States $0.911B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.892B 0.00
Amarin (AMRN) Ireland $0.867B 0.00
AUTOLUS THERAPT (AUTL) United Kingdom $0.844B 0.00
ANI Pharmaceuticals (ANIP) United States $0.827B 16.92
Heska (HSKA) United States $0.803B 61.52
Inotek Pharmaceuticals (RCKT) United States $0.790B 0.00
Sorrento Therapeutics (SRNE) United States $0.785B 0.00
InflaRx (IFRX) Germany $0.775B 0.00
EIDOS THERAPEUT (EIDX) United States $0.770B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.757B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.748B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.748B 0.00
AC Immune SA (ACIU) Switzerland $0.708B 0.00
Cara Therapeutics (CARA) United States $0.706B 0.00
AVROBIO INC (AVRO) United States $0.672B 0.00
Abeona Therapeutics (ABEO) United States $0.669B 0.00
Kura Oncology (KURA) United States $0.665B 0.00
APTINYX INC (APTX) United States $0.665B 0.00
UROGEN PHARMA (URGN) Israel $0.660B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.659B 0.00
UNITY Biotechnology (UBX) $0.639B 0.00
Mesoblast (MESO) Australia $0.636B 0.00
Arbutus Biopharma (ABUS) Canada $0.626B 0.00
Geron (GERN) United States $0.621B 0.00
Fate Therapeutics (FATE) United States $0.618B 0.00
Five Prime Therapeutics (FPRX) United States $0.615B 0.00
Tigenix (TIG) Belgium $0.605B 0.00
Viking Therapeutics (VKTX) United States $0.603B 0.00
Senesco Technologies (ELOX) United States $0.589B 0.00
Prothena (PRTA) Ireland $0.573B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.565B 0.00
ObsEva SA (OBSV) Switzerland $0.562B 0.00
BeyondSpring (BYSI) United States $0.555B 0.00
Merus (MRUS) Netherlands $0.552B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.540B 0.00
Aduro Biotech (ADRO) United States $0.539B 0.00
Novavax (NVAX) United States $0.534B 0.00
Anika Therapeutics (ANIK) United States $0.513B 20.36
Arcus Biosciences (RCUS) United States $0.494B 0.00
Stemline Therapeutics (STML) United States $0.487B 0.00
Cytokineticsorporated (CYTK) United States $0.477B 0.00
Zealand Pharma (ZEAL) Denmark $0.476B 0.00
MAGENTA THERAPT (MGTA) United States $0.475B 0.00
Zymeworks (ZYME) Canada $0.471B 0.00
Verastem (VSTM) United States $0.464B 0.00
Evelo Biosciences (EVLO) United States $0.440B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.439B 0.00
Sinovac Biotech (SVA) China $0.434B 0.00
Syros Pharmaceuticals (SYRS) United States $0.415B 0.00
Unum Therapeutics (UMRX) United States $0.412B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.408B 0.00
Albireo Pharma (ALBO) United States $0.400B 0.00
Inovio Pharmaceuticals (INO) United States $0.390B 0.00
PDL BioPharma (PDLI) United States $0.386B 3.94
Vericel (VCEL) United States $0.378B 0.00
Scholar Rock Holding (SRRK) United States $0.372B 0.00
MiMedx (MDXG) United States $0.370B 15.86
MediciNova (MNOV) United States $0.369B 0.00
Mersana Therapeutics (MRSN) United States $0.366B 0.00
RA PHARMCTL INC (RARX) United States $0.361B 0.00
Kindred Biosciences (KIN) United States $0.354B 0.00
Cellular Biomedicine (CBMG) United States $0.346B 0.00
GTx (GTXI) United States $0.346B 0.00
Vital Therapies (VTL) United States $0.339B 0.00
Clearside Biomedical (CLSD) United States $0.331B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.330B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.330B 0.00
Adverum Biotechnologies (ADVM) United States $0.328B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.328B 0.00
Seres Therapeutics (MCRB) United States $0.325B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.307B 0.00
Kala Pharmaceuticals (KALA) United States $0.307B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.300B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.300B 0.00
Celyad SA (CYAD) Belgium $0.299B 0.00
BioTime (BTX) United States $0.292B 0.00
KEZAR LIFE SCI (KZR) United States $0.292B 0.00
Selecta Biosciences (SELB) United States $0.291B 0.00
MEIRAGTX HLDGS (MGTX) United States $0.287B 0.00
Synlogic (SYBX) United States $0.281B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.281B 0.00
Athersys (ATHX) United States $0.279B 0.00
Kadmon Holdings (KDMN) United States $0.269B 0.00
Axovant Sciences (AXON) United Kingdom $0.266B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.257B 0.00
OVID THERAPEUTC (OVID) United States $0.256B 0.00
ResTORbio (TORC) United States $0.243B 0.00
Strongbridge Biopharma (SBBP) United States $0.241B 0.00
NantKwest (NK) United States $0.241B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.239B 0.00
ChromaDex (CDXC) United States $0.234B 0.00
Allena Pharmaceuticals (ALNA) United States $0.233B 0.00
Enzo Biochem (ENZ) United States $0.232B 0.00
Celcuity (CELC) United States $0.229B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.228B 0.00
Cue Biopharma (CUE) United States $0.227B 0.00
Kamada (KMDA) Israel $0.225B 18.07
Agenus (AGEN) United States $0.224B 0.00
Cohbar (CWBR) United States $0.222B 0.00
MannKind (MNKD) United States $0.221B 0.00
ADMA Biologics Inc (ADMA) United States $0.219B 0.00
Signal Genetics (MGEN) United States $0.216B 0.00
Idera Pharmaceuticals (IDRA) United States $0.212B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.202B 0.00
Palatin Technologies (PTN) United States $0.201B 7.77
Aeglea BioTherapeutics (AGLE) United States $0.198B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.197B 0.00
Mustang Bio (MBIO) United States $0.196B 0.00
XOMA (XOMA) United States $0.194B 14.73
Monster Digital (INNT) United States $0.191B 0.00
TOCAGEN INC (TOCA) United States $0.187B 0.00
VBI Vaccines (VBIV) United States $0.185B 0.00
Krystal Biotech (KRYS) United States $0.184B 0.00
BioXcel Therapeutics (BTAI) United States $0.184B 0.00
Menlo Therapeutics (MNLO) United States $0.183B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.182B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.178B 0.00
NewLink Genetics (NLNK) United States $0.175B 0.00
Spero Therapeutics (SPRO) United States $0.168B 0.00
Protagonist Therapeutics (PTGX) United States $0.167B 0.00
Compugen (CGEN) Israel $0.167B 0.00
BioDelivery Sciences (BDSI) United States $0.166B 0.00
Bellerophon Therapeutics (BLPH) United States $0.157B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.156B 0.00
XBiotech (XBIT) United States $0.153B 0.00
Intec Pharma (NTEC) Israel $0.149B 0.00
Organovo Holdings (ONVO) United States $0.149B 0.00
Fortress Biotech (FBIO) United States $0.148B 0.00
Catalyst Biosciences (CBIO) United States $0.145B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.143B 0.00
Pluristem Therapeutics (PSTI) Israel $0.142B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.138B 0.00
Anavex Life Sciences (AVXL) United States $0.138B 0.00
Cerecor (CERC) United States $0.137B 21.90
Motif Bio Plc (MTFB) United States $0.133B 0.00
Cocrystal Pharma (COCP) United States $0.132B 0.00
Cidara Therapeutics (CDTX) United States $0.131B 0.00
Pfenex (PFNX) United States $0.126B 0.00
Leap Therapeutics (LPTX) United States $0.121B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.116B 0.00
PSivida (EYPT) United States $0.115B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.113B 0.00
Aptose Biosciences (APTO) Canada $0.112B 0.00
Gemphire Therapeutics (GEMP) United States $0.111B 0.00
Trevena (TRVN) United States $0.107B 0.00
Aptevo Therapeutics (APVO) United States $0.107B 0.00
Tapimmune (TPIV) United States $0.106B 0.00
Proteostasis Therapeutics (PTI) United States $0.100B 0.00
Asterias Biotherapeutics (AST) United States $0.099B 0.00
GENPREX INC (GNPX) United States $0.098B 0.00
Ophthotech (OPHT) United States $0.096B 0.66
Eleven Biotherapeutics (SESN) United States $0.094B 0.00
Sophiris Bio (SPHS) United States $0.093B 0.00
Alcobra (ARCT) Israel $0.091B 0.00
ScPharmaceuticals (SCPH) United States $0.090B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.090B 0.00
Oncolytics Biotech (ONCY) Canada $0.089B 0.00
Orgenesis (ORGS) United States $0.088B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.085B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.083B 0.00
Axsome Therapeutics (AXSM) United States $0.081B 0.00
Checkpoint Therapeutics (CKPT) United States $0.080B 0.00
VIVUS (VVUS) United States $0.080B 0.00
Evogene (EVGN) Israel $0.076B 0.00
Applied Genetic Technologies (AGTC) United States $0.075B 0.00
Celldex Therapeutics (CLDX) United States $0.074B 0.00
Advaxis (ADXS) United States $0.074B 0.00
ENTERA BIO LTD (ENTX) Israel $0.074B 0.00
Alimera Sciences (ALIM) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.072B 0.00
Histogenics (HSGX) United States $0.070B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.070B 0.00
Aileron Therapeutics (ALRN) United States $0.068B 0.00
OncoSec Medical (ONCS) United States $0.068B 0.00
Eyenovia (EYEN) United States $0.067B 0.00
Neothetics (EVFM) United States $0.066B 0.00
Protalix BioTherapeutics (PLX) Israel $0.065B 0.00
Vascular Biogenics (VBLT) Israel $0.064B 0.00
Novelion Therapeutics (NVLN) Canada $0.063B 0.00
VolitionRX (VNRX) Singapore $0.059B 0.00
Curis (CRIS) United States $0.058B 0.00
Zosano Pharma (ZSAN) United States $0.056B 0.00
Caladrius Biosciences (CLBS) United States $0.055B 0.00
Celsion (CLSN) United States $0.051B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
AZURRX BIOPHARM (AZRX) United States $0.047B 0.00
TRACON Pharmaceuticals (TCON) United States $0.046B 0.00
Moleculin Biotech (MBRX) United States $0.046B 0.00
Arsanis (ASNS) United States $0.044B 0.00
Proteon Therapeutics (PRTO) United States $0.043B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.043B 0.00
CytRx (CYTR) United States $0.041B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
Cellect Biotechnology (APOP) Israel $0.040B 0.00
BioPharmX (BPMX) United States $0.038B 0.00
Chiasma (CHMA) United States $0.038B 0.00
OvaScience (OVAS) United States $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Edge Therapeutics (EDGE) United States $0.032B 0.00
AEterna Zentaris (AEZS) United States $0.032B 0.00
Benitec Biopharma (BNTC) Australia $0.031B 0.00
Oncobiologics (ONS) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.028B 0.00
Synthetic Biologics (SYN) United States $0.027B 0.00
ATyr Pharma (LIFE) United States $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
RestorGenex (DFFN) United States $0.024B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.023B 0.00
Genetic Technologies (GENE) Australia $0.022B 0.00
CorMedix Inc (CRMD) United States $0.021B 0.00
Pulmatrix (PULM) United States $0.021B 0.00
Prana Biotechnology (PRAN) Australia $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Neuralstem (CUR) United States $0.018B 0.00
Cel-Sci (CVM) United States $0.018B 0.00
AmpliPhi Biosciences (APHB) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Cerulean Pharma (DARE) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Flex Pharma (FLKS) United States $0.015B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Fibrocell Science Inc (FCSC) United States $0.013B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.95
ContraVir Pharmaceuticals Inc (CTRV) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Galena Biopharma (SLS) United States $0.011B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.010B 0.00
IBio (IBIO) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
Soligenix (SNGX) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Immune Pharmaceuticals (IMNP) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Oragenics (OGEN) United States $0.004B 0.00
TrovaGene (TROV) United States $0.004B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00